Amanote Research
Register
Sign In
P1.15-33 Real-World Data on Prognostic Factors for Overall Survival in NSCLC Patients Treated With Bevacizumab Combination Therapy
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.966
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
S. Wu
W. Liao
C. Ho
J. Shih
C. Yu
Publisher
Elsevier BV
Related search
P3.08-06 Long-Term Survival for Brain-Only Oligometastatic NSCLC Patients Treated With Ablative Therapy (AT): Prognostic Factors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Factors Affecting Overall Survival and Local Recurrence in Meningioma Patients Treated With Radiation Therapy or Combined Radiation Therapy and Surgery
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
P1.01-04 Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
P1.15-03 Clinical Characteristics of Long-Term Survivors With Nivolumab in Pretreated Advanced NSCLC From Real-World Data (RWD)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Analysis of Overall Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Vaccine, Nilutamide, and Combination Therapy
Clinical Cancer Research
Cancer Research
Oncology
Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab
Clinical Medicine Insights: Oncology
Oncology
Prognostic Factors for Patients Treated With Abiraterone
Future Science OA
Medicine
Biotechnology
Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival
Molecular and Clinical Oncology
Cancer Research
Oncology